Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
11/2003
11/20/2003US20030216338 Bacteriophage having multiple host range
11/20/2003US20030216285 Selected from the group consisting of alloxazines and photosensitizers
11/20/2003US20030215942 Preparing stem cell libraries for therapeutic use in event of exposure to nuclear radiation
11/20/2003US20030215921 Vascular endothelial growth factor-2
11/20/2003US20030215898 Methods for using 22045, a human cyclic nucleotide phosphodiesterase
11/20/2003US20030215831 Renal regulatory elements and methods of use thereof
11/20/2003US20030215808 Selecting, screening or characterizing a compound by contacting it with lymphocytes and determing it ability to regulate activity
11/20/2003US20030215785 Solution containing platelet activation inhibitors for pathogen reducing and storing blood platelets
11/20/2003US20030215506 Methods and compositions for enhancement of creatine transport
11/20/2003US20030215480 For use against plant parasitic nematodes; waste treatment
11/20/2003US20030215467 Isolated from resected and washed human gastrointestinal tract; for oral administration; probiotics
11/20/2003US20030215461 Immunogenic composition comprising adenyl cyclase-hemolysin protein, or portion thereof, strain of Bordetella chosen from B.pertussis, B.parapertussis or B.bronchiseptica, bacterial extract containing expression product of bordetella vrg genes
11/20/2003US20030215460 Methods and compositions for inducing an immune response
11/20/2003US20030215443 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
11/20/2003US20030215429 Lyophilised or sonicated Lactobacillus bacteria, grampositivie bacteria, gramnegative bacteria; antitumor agents, therapeutic treatment of autoimmune diseases, gastrointestinal disorders, nervodegenerative diseases
11/20/2003CA2487280A1 System and method for forming a substantially non-ablative cardiac conduction block
11/20/2003CA2487254A1 System and method for treating cardiac arrhythmias with fibroblast cells
11/20/2003CA2485655A1 Recombinant fowlpox virus
11/20/2003CA2485567A1 Treatments with autologous fibroblast
11/20/2003CA2484607A1 Methods and compositions for inducing an immune response
11/20/2003CA2484398A1 Method for reducing pain using oncolytic viruses
11/20/2003CA2484144A1 Eif-5a nucleic acids for inhibiting apoptosis
11/20/2003CA2483046A1 Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
11/20/2003CA2462203A1 Methods and products for enhancing immune responses using imidazoquinoline compounds
11/19/2003EP1362596A2 Inhibitor of stem cell proliferation and uses thereof
11/19/2003EP1362104A2 T cell receptor variants expressed in mesenchymal cells and uses thereof
11/19/2003EP1362096A2 Pigmentary epithelium cell of the eye, the production thereof and the use of the same for treating diseases of the eye or of the central nervous system
11/19/2003EP1362095A2 Post-partum mammalian placenta, its use and placental stem cells therefrom
11/19/2003EP1361896A2 Localized myocardial injection method for treating ischemic myocardium
11/19/2003EP1361888A2 Method of treating neurologcial diseases
11/19/2003EP1361884A2 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
11/19/2003EP1214080B1 Glucosamine and hyperimmune egg for reducing inflammation
11/19/2003EP1096942B1 Use of a medicine containing a quantity of tyrothricine for the treatment of viral infections
11/19/2003EP0815144B1 Therapeutic uses of glucan
11/19/2003CN1457259A Method for preventing and curing diseases of immune system and remedy for carrying out said method
11/19/2003CN1456341A Lung clearing oral liquid preparation for treating viral pneumonia in Children and preparing method thereof
11/19/2003CN1456340A External applied pedicure ointment
11/19/2003CN1456338A Medicine for treating diabets mellitus
11/19/2003CN1456313A Tiegudan for ischemic necrosis of fernoral head
11/19/2003CN1456277A Medicine for treating cirrhosis
11/19/2003CN1456227A Medicine for curing hepatitis B
11/19/2003CN1456217A Medicine for curing choleithiasis and preparing method thereof
11/19/2003CN1456203A Chinese medicine preparation against cold
11/19/2003CN1456198A Angong hemostatics
11/19/2003CN1456178A External applied medicine for curing burn and preparing method thereof
11/19/2003CN1456177A Method and apparatus for producing fibroin powder
11/19/2003CN1456176A Pearl nano-materials preparing method
11/19/2003CN1456175A Pelma musk contraceptive paste and preparing method thereof
11/19/2003CN1456174A Anti-anoxia anti-fatigue biological preparation for improving human
11/19/2003CN1456173A High-efficiency fast styptic
11/19/2003CN1456170A External applied medicine composition containing vitamin š�*
11/19/2003CN1456107A Healthy beverage
11/19/2003CN1128220C Process for separating worm kinase
11/19/2003CN1127979C Medicine 'Buyuan Jianmei Wan'
11/19/2003CN1127978C Hyperosteogeny treating medicine
11/19/2003CN1127974C Chinese medicinal preparation for fracture
11/19/2003CN1127973C Medicine for hepatitis
11/19/2003CN1127972C Medicine for cancers and its preparation
11/19/2003CN1127971C Medicine for senile dementia
11/19/2003CN1127970C Ointment for treating burn and its preparing process
11/19/2003CN1127969C Medicinal spirit for hyperosteogeny
11/19/2003CN1127967C Capsules for hypertension and their preparation
11/19/2003CN1127964C Chinese medicine for treating dermatopathy (leukoderma and psoriasis)
11/19/2003CN1127963C Oral liquid of chitosan and lucid ganoderma and its preparing process
11/19/2003CN1127962C Capsule for curing hydrocephalus and its producing method
11/19/2003CN1127948C Microencapsulated bovine adrenal medulla chromaffin cell-drug for alleviating pain
11/18/2003US6649590 Heating; removal precipitates; recovering; ultrafiltration; ion exchange resin
11/18/2003US6649391 Isolated polynucleotide encoding a polypeptide of given sequence; dephosphorylates MAP(mitogen activated protein)-kinase; used for modulating cell proliferation, differentiation and survival
11/18/2003US6649386 Stability; for reconstitution with water; antihemophilic factor; blood factor IX
11/18/2003US6649375 Adenoviral vectors for enhanced gene expression
11/18/2003US6649373 Use of trans-activation and CIS-activation to modulate the persistence of expression of a transgene
11/18/2003US6649339 Screening for the presence of a parvovirus genome equivalent using nucleic acid amplification; purification
11/18/2003US6649194 Topical analgesics and methods of use
11/18/2003US6649185 For the treatment of cancer; particularly, the formulation can be used to treat haematological malignancies
11/18/2003US6649160 Sertoli cells as transplantation facilitator for cell transplantation
11/18/2003US6649157 Treating a Ras-mediated cell proliferative disorder in a mammal, by administering a modified adenovirus, modified HSV, modified vaccinia virus or modified parapoxvirus orf virus resulting in lysis of the proliferating cells.
11/15/2003CA2386550A1 Method and system for modulation and modification of microbial cell characteristics and production of modified microbial materials
11/13/2003WO2003093740A1 Container for transporting biological material
11/13/2003WO2003093512A1 Methods and compositions for the modification of nucleic acids
11/13/2003WO2003093485A2 Optimization of transgene expression in mammalian cells
11/13/2003WO2003093463A1 Improved viral purification methods
11/13/2003WO2003093462A2 Immobilisation and stabilisation of virus
11/13/2003WO2003093458A1 Isolation of target cells, capillaries and microorgans
11/13/2003WO2003093455A2 Adenovirus vectors for immunotherapy
11/13/2003WO2003093431A2 Ablated slam-dependent entry
11/13/2003WO2003093418A2 Keratinocytes expressing exogenous angiogenic growth factors
11/13/2003WO2003092894A2 Method and apparatus for isolating platelets from blood
11/13/2003WO2003092745A1 Methods for sterilizing tissues using cryopreservatives
11/13/2003WO2003092738A1 Drug- or gene-carrier composition having lowered hemagglutinin activity
11/13/2003WO2003092717A1 Cancer immunotherapy
11/13/2003WO2003092715A2 Proteins involved in the regulation of energy homeostasis
11/13/2003WO2003092711A1 Method of enhancing biological activity of plant extracts
11/13/2003WO2003092708A1 Antitumor agents with the use of hsv
11/13/2003WO2003092657A1 Microparticles bearing cells and active substances
11/13/2003WO2003092653A1 Apparatus and method for delivery of bacteria to the vaginal tract
11/13/2003WO2003092615A2 Use of anti-cd1 antibodies for the modulation of immune responses
11/13/2003WO2003092612A2 VECTORS HAVING BOTH ISOFORMS OF β-HEXOSAMINIDASE
11/13/2003WO2003092604A2 Vascularization enhanced graft constructs
11/13/2003WO2003092579A2 Compositions and methods for treating cancer with an oncolytic viral agent
11/13/2003WO2003092474A2 Vascularization enhanced graft constructs